Concepedia

Mucosal irritative and healing impairment action of risedronate in rat stomachs: Comparison with alendronate

Kenji Kanatsu, Eitaro Aihara, MITUAKI OKAYAMA, Shinichi Kato, Koji Takeuchi

Journal of Gastroenterology and Hepatology · 2004 · 24 citations · 23 references

DOI

Abstract

Both alendronate and risedronate have mucosal irritative and healing impairing effects in the stomach, yet the effect of risedronate was much less pronounced compared to alendronate. It is assumed that risedronate is safer than alendronate as the antiresorptive agent in patients with diseases related to bone remodeling.

References

23

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.8K citations

, , +5

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Jean‐Yves Reginster, H. W. Minne, O. H. Sørensen et al. · Osteoporosis International · 2000 · 1.6K citations

, , +6

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

Steven P. Luckman, D. E. Hughes, Fraser P. Coxon et al. · Journal of Bone and Mineral Research · 1998 · 1.2K citations · Full text

, , +25

Risedronate Reverses Bone Loss in Postmenopausal Women with Low Bone Mass: Results From a Multinational, Double-Blind, Placebo-Controlled Trial<sup>1</sup>

Ignac Fogelman, C Ribot, Roger Smith et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 198 citations · Full text

Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women

Frank L. Lanza, Richard H. Hunt, A. B. R. Thomson et al. · Gastroenterology · 2000 · 194 citations · Full text

, , +7